Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL

NCT02080234 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Extranodal NK-T-Cell

Interventions

DRUG: GELOX
RADIATION: IFRT

Sponsor

Sun Yat-sen University